Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups

Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups

Introduction: This research aims to explore the performance of the SF-6D and the EQ-5D in patients suffering from asthma, chronic obstructive pulmonary disease, cataracts, and rheumatoid arthritis. In particular, the aim of this research is twofold: 1) to study the level of agreement between the in...

Full description

Bibliographic Details
Main Authors:	Lara N. Ferreira, Pedro L. Ferreira, Luis N. Pereira
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2014-04-01
Series:	Acta Médica Portuguesa
Online Access:	https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4057

Similar Items

Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis
by: Clara Mukuria, et al.
Published: (2024-02-01)

Contributos para a Validação da Versão Portuguesa do EQ-5D
by: Pedro Lopes Ferreira, et al.
Published: (2013-12-01)

An empirical evaluation of the SF-12, SF-6D,EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
by: Dritsaki, M, et al.
Published: (2017)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
by: Nikolaos Kontodimopoulos, et al.
Published: (2022-07-01)

Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students
by: Hui Jun Zhou, et al.
Published: (2023-11-01)

Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China
by: Shitong Xie, et al.
Published: (2023-10-01)

The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP)
by: Janine Verstraete, et al.
Published: (2022-12-01)

Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
by: Holle Rolf, et al.
Published: (2010-04-01)

Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.
by: Gray, A, et al.
Published: (2006)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
by: Nasrin Moradi, et al.
Published: (2022-12-01)

Comparison of the CQ-11D, SF-6Dv1 and EQ-5D-3L Contemporaneous Utility Scores in Patients with Chronic Disease
by: WANG Wei, XIE Shitong, ZHOU Jiameng, PAN Jie, ZHU Wentao
Published: (2023-09-01)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
by: Elena Olariu, et al.
Published: (2023-07-01)

Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery.
by: Dawson, J, et al.
Published: (2012)

Responsiveness of the Manchester-Oxford foot questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery
by: Dawson, J, et al.
Published: (2012)

eq5d: A command to calculate index values for the EQ-5D quality-of-life instrument
by: Manuel Ramos-Goni, J, et al.
Published: (2011)

EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report
by: Titi Sahidah Fitriana, et al.
Published: (2022-06-01)

Exploring differences and similarities of EQ-5D-3L, EQ-5D-5L and WHOQOL-OLD in recipients of aged care services in Germany.
by: Ole Marten, et al.
Published: (2023-01-01)

QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia
by: Tianxin Pan, et al.
Published: (2023-12-01)

Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents
by: Janine Verstraete, et al.
Published: (2022-06-01)

Validation of general questionnaire EuroQol-5D (EQ-5D) Russian version
by: V N Amirdjanova, et al.
Published: (2007-06-01)

Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36
by: Jirat Temsangsukmanee, et al.
Published: (2023-09-01)

Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi
by: Ngwira, LG, et al.
Published: (2023)

Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi
by: Lucky G. Ngwira, et al.
Published: (2023-03-01)

VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA
by: A. I Akulova, et al.
Published: (2018-07-01)

Performance of the EQ-5D-Y Interviewer Administered Version in Young Children
by: Razia Amien, et al.
Published: (2022-01-01)

ESTIMATING THE ASSOCIATION BETWEEN SF-12 RESPONSES TO EQ-5D UTILITY VALUES USING A RESPONSE MAPPING AND A PARAMETER UNCERTAINTY APPROACH
by: Rivero-Arias, O, et al.
Published: (2010)

The international valuation protocol for the EQ-5D-Y-3L
by: Ramos-Goni, JM, et al.
Published: (2020)

Valuation Of Eq-5d-5l Study For The Malaysian Population
by: Thakumar, Annushiah Vasan
Published: (2020)

Valuation Of Eq-5d-5l Study For The Malaysian Population
by: Thakumar, Annushiah Vasan
Published: (2020)

Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review
by: Anju D. Keetharuth, et al.
Published: (2022-09-01)

Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health
by: Maryna Derkach, et al.
Published: (2022-06-01)

EQ-5D in Central and Eastern Europe: 2000–2015
by: Rencz, F, et al.
Published: (2017)

EQ-5D Value Sets [electronic resource]: Inventory, Comparative Review and User Guide/
by: Szende, Agota, et al.
Published: (2007)

Mapping the Oxford hip score onto the EQ-5D utility index.
by: Pinedo-Villanueva, R, et al.
Published: (2013)

VALIDATION OF EQ-5D AND HADS INDICES TO EVALUATE QUALITY OF LIFE IN PATIENTS WITH PANNICULITIS
by: N. M. Savushkina, et al.
Published: (2017-04-01)

Health inequity assessment in Brazil: is EQ-5D-3L sensible enough to detect differences among distinct socioeconomic groups?
by: Bernardo Rangel Tura, et al.
Published: (2024-02-01)

EQ-5D in dialysis units: a PROM with a view
by: Inês Sala, et al.
Published: (2022-12-01)

Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis
by: Roberta Gualtierotti, et al.
Published: (2016-12-01)

A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China
by: Ruo-Yu Zhang, et al.
Published: (2022-05-01)

Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden
by: Fitsum Sebsibe Teni, et al.
Published: (2023-04-01)